Patents
Literature
Eureka-AI is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Eureka AI

8608 results about "Porosity" patented technology

Porosity or void fraction is a measure of the void (i.e. "empty") spaces in a material, and is a fraction of the volume of voids over the total volume, between 0 and 1, or as a percentage between 0% and 100%. Strictly speaking, some tests measure the "accessible void", the total amount of void space accessible from the surface (cf. closed-cell foam). There are many ways to test porosity in a substance or part, such as industrial CT scanning. The term porosity is used in multiple fields including pharmaceutics, ceramics, metallurgy, materials, manufacturing, hydrology, earth sciences, soil mechanics and engineering.

Endovascular graft with differentiable porosity along its length

InactiveUS20050137677A1Promote tissue in-growthAchieve effectSuture equipmentsStentsPorosityYarn
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device such as a stent-graft. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. A stent-graft fabricated from a thin-walled, high strength material provides for a more durable and lower profile endoprosthesis. The stent-graft comprises one or more stent segments covered with a fabric formed by the weaving, knitting or braiding of a biocompatible, high tensile strength, abrasion resistant, highly durable yarn such as ultra high molecular weight polyethylene. The one or more stent segments may be balloon expandable or self-expanding. The fabric may be attached to the stent segments utilizing any number of known materials and techniques. In addition, the pore size of the graft material may be varied.
Owner:CORDIS CORP

Method for manufacture of minimum porosity, wrinkle free composite parts

A process and associated apparatus used to prepare a thermoplastic composite from a plurality of plies of thermoplastic resin prepregs. The prepregs are formed into a composite structure under two chambers; a rigid outer chamber (of any convenient size or shape) and a second flexible inner chamber containing a prepreg lay-up. The absolute pressures are reduced concurrently in a stepwise method in both chambers. This concurrent, stepped pressure reduction is accomplished at a rate which prevents the vacuum bag from moving far from the prepregs, and prevents wrinkles from forming in the prepregs. Pinching off the diffusion paths required for the removal of unwanted gases is eliminated. The lay-up is then heated and the absolute pressure in the outer rigid chamber is increased. This pressure constrains the flexible inner chamber during out-gassing of the thermoplastic resin, preventing wrinkles from forming in the prepregs. The absolute pressure in the outer rigid chamber is increased to atmospheric pressure or greater causing the prepregs to consolidate. A low absolute pressure is maintained in the flexible inner chamber. The temperature is then increased to the cure temperature of the resin and held for a time sufficient for the resin to cure. The resulting consolidated thermoplastic resin is substantially void free and detectable wrinkles are absent.
Owner:HALE HAROLD P
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products